nickel and moxifloxacin

nickel has been researched along with moxifloxacin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Djurdjevic, P; Ivanovic, N; Jakovljevic, I; Jelikic-Stankov, M; Joksovic, L	1
Aldred, KJ; Breland, EJ; Kerns, RJ; McPherson, SA; Osheroff, N; Turnbough, CL	1

Other Studies

2 other study(ies) available for nickel and moxifloxacin

Article	Year
The effect of some fluoroquinolone family members on biospeciation of copper(II), nickel(II) and zinc(II) ions in human plasma. Molecules (Basel, Switzerland), 2014, Aug-13, Volume: 19, Issue:8 Topics: Ciprofloxacin; Coordination Complexes; Copper; Fluoroquinolones; Humans; Ions; Levofloxacin; Moxifloxacin; Nickel; Ofloxacin; Zinc	2014
Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Alanine; Anti-Bacterial Agents; Bacillus anthracis; Cations, Divalent; Ciprofloxacin; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Manganese; Models, Molecular; Moxifloxacin; Mutation; Nickel; Protein Subunits; Recombinant Proteins; Topoisomerase Inhibitors; Valine; Water	2014

Article

Year

The effect of some fluoroquinolone family members on biospeciation of copper(II), nickel(II) and zinc(II) ions in human plasma.

Molecules (Basel, Switzerland), 2014, Aug-13, Volume: 19, Issue:8

Topics: Ciprofloxacin; Coordination Complexes; Copper; Fluoroquinolones; Humans; Ions; Levofloxacin; Moxifloxacin; Nickel; Ofloxacin; Zinc

2014

Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge.

Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

Topics: Alanine; Anti-Bacterial Agents; Bacillus anthracis; Cations, Divalent; Ciprofloxacin; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Manganese; Models, Molecular; Moxifloxacin; Mutation; Nickel; Protein Subunits; Recombinant Proteins; Topoisomerase Inhibitors; Valine; Water

2014